4//SEC Filing
Gilmartin Geoffrey S. 4
Accession 0001209191-19-016549
CIK 0001445283other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:37 PM ET
Size
6.0 KB
Accession
0001209191-19-016549
Insider Transaction Report
Form 4
Gilmartin Greffrey S.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-03-01+53,450→ 53,450 totalExercise: $4.30Exp: 2029-03-01→ Common Stock (53,450 underlying)
Footnotes (1)
- [F1]These securities shall vest and become exercisable in a series of installments, with the first installment to become exercisable for 25% of the underlying common stock on February 5, 2020, and thereafter vesting and becoming exercisable in 12 quarterly installments as nearly equal as practicable (as determined by the Issuer in its reasonable discretion), until such stock option becomes fully exercisable on February 5, 2023, provided that the Reporting Person remains an employee of Issuer at all times during the applicable vesting period of such securities.
Documents
Issuer
PROTEOSTASIS THERAPEUTICS, INC.
CIK 0001445283
Entity typeother
Related Parties
1- filerCIK 0001688268
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:37 PM ET
- Size
- 6.0 KB